Upload
theodore-marshall
View
223
Download
5
Tags:
Embed Size (px)
Citation preview
Heart Failure
John Lynn Jefferies, MD, MPH,FAAP, FACC
Director, Cardiomyopathy, Advanced Heart Failure, and Ventricular Assist Device Programs
Co-Director, Cardiovascular GeneticsAssociate Professor, Pediatric Cardiology and
Adult Cardiovascular Diseases The Heart Institute
Cincinnati Children’s Hospital
HEART FAILURE DEFINED
“Heart failure is a complex clinical syndrome that canresult from any structural
or functional cardiac disorder that impairs the ability of the ventricle to fill with
or eject blood.”
Hunt SA et al. Circulation. 2001;104:2996
Heart Failure: Why the Concern?
• One in 8 deaths in the US has HF listed on the death certificate
• Cost to the US for HF treatment was 39.2 billion dollars in 2010
• To deliver more specialized care in this area, most adult programs have developed HF programs
Heart Failure: Why the Concern?• More than 5 million people in the US with the
diagnosis of HF• Over 600,000 new diagnoses each year• Underestimates the pediatric and ACHD
population• Many insurers are recognizing the importance
of specialized care in their reimbursement
Heart Failure
• Heart Failure is a common problem world-wide
• Historically thought of as volume overload• Current thought that this is a clinical syndrome• Should never be thought about as a “stand
alone” diagnosis• Causes can be numerous• May have multiple etiologies in any patient
Symptoms• Can be quite variable based on age of patient and
phenotype– Swelling–Dyspnea on exertion–Palpitations–Weight gain– Syncope
• Most common symptom in pediatric population – None– Failure to thrive, not meeting milestones
ANPBNP
Myocardial Injury Fall in LV Performance
Activation of RAAS and SNS(endothelin, AVP, cytokines)
Myocardial ToxicityChange in Gene Expression
Peripheral Vasoconstriction Sodium/Water Retention
HF SymptomsMorbidity and Mortality
Remodeling andProgressive
Worsening ofLV Function
Shah M et al. Rev Cardiovasc Med. 2001;2(suppl 2):S2
The Heart Failure Syndrome
11
Final Common Pathways
ACTC
Impaired
force
transmission
MYH7 TNNC1 TNNT2
TPM1
Impaired
force
generation
LMNA
Changes in nuclear structure
and function
LDB3
Changes in
stretch sensor
machinery
PLN
Calcium regulati
on
DILATED CARDIOMYOPATHY
SCN5A
Sodium regulati
on
Cardiomyopathies
• Hypertrophic Cardiomyopathy (HCM)• Dilated Cardiomyopathy (DCM)• Restrictive Cardiomyopathy (RCM)• Left Ventricular Noncompaction (LVNC)• Arrhythmogenic Right Ventricular
Cardiomyopathy (ARVC)
Systolic Heart Failure• Depressed ventricular function• Classically describing the left ventricle• Increasingly described in the right ventricle or in
both ventricles• Noninvasive imaging typical mode of diagnosis– Echocardiography, CT, MRI, Nuclear, Invasive
Angiography• In adults, typical cause is ischemic• In children, infectious or genetic more common
Heart Failure With Preserved Ejection Fraction (HFpEF)
• Formerly known as diastolic heart failure• 50% of adult heart failure cases–Unknown prevalence in children
• Outcome similar to those patients with HF and systolic dysfunction
• Increasing in incidence compared to HFrEF• Treatment options not as robust• Continuum of myocardial dysfunction?
Increasing Need• Difficult to assess the prevalence of
cardiomyopathy accurately• ~5 million Americans suffer from symptomatic
heart failure• Estimated 50 million Americans meet criteria for
Stage A or B• We expect this underestimates the at risk
populations– Underuse of appropriate screening for at risk
populations
Conclusions
• Heart failure is a complex clinical syndrome• Proper management dependent on recognition of
appropriate components of care– Not just diuresis and inotropes
• Understanding etiology often more challenging in pediatric populations
• Collaborative approach with multiple disciplines including Nephrology leads to best outcome